NASDAQ: TSBX
Turnstone Biologics Corp Stock Ownership - Who owns Turnstone Biologics?

Insider buying vs selling

Have Turnstone Biologics Corp insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when TSBX insiders and whales buy or sell their stock.

TSBX Shareholders

What type of owners hold Turnstone Biologics Corp stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Davis Jerel14.61%3,381,692$1.15MInsider
Versant Ventures V LLC14.61%3,381,692$1.15MInsider
Orbimed Advisors LLC13.39%3,099,265$1.05MInsider
Rishi Gupta13.39%3,099,265$1.05MInsider
Orbimed Advisors LLC13.39%3,099,265$1.05MInstitution
Fmr LLC5.12%1,184,043$402.57kInstitution
Fmr LLC4.90%1,133,987$385.56kInsider
Point72 Asset Management LP4.04%934,364$317.68kInstitution
Pfm Health Sciences LP4.03%932,348$317.00kInstitution
Takeda Pharmaceutical Co Ltd3.87%895,824$304.58kInstitution

1 of 3

TSBX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TSBX44.05%55.95%
CHRO0.41%58.56%Net Buying
LYRA40.81%15.59%
EVGN6.17%0.00%
SLXN1.67%68.33%

Turnstone Biologics Stock Ownership FAQ

Who owns Turnstone Biologics?

Turnstone Biologics (NASDAQ: TSBX) is owned by 47.96% institutional shareholders, 60.92% Turnstone Biologics insiders, and 0.00% retail investors. Davis Jerel is the largest individual Turnstone Biologics shareholder, owning 3.38M shares representing 14.61% of the company. Davis Jerel's Turnstone Biologics shares are currently valued at $1.14M.

If you're new to stock investing, here's how to buy Turnstone Biologics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.